Loading clinical trials...
Loading clinical trials...
A Disease Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Conditions
Locations
12
Cyprus
Bank of Cyprus Oncology Center
Nicosia, Cyprus
Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine
Athens, Greece
Anticancer Hospital Ag. Savas ; 2Nd Dept. of Oncology - Internal Medicine
Athens, Greece
ARETAIEION UNIVERSITY HOSPITAL; oncology unit
Athens, Greece
251 Air Force General Hospital-Oncology Clinic
Athens, Greece
Agioi Anargyroi; 3Rd Dept. of Medical Oncology
Athens, Greece
Start Date
October 30, 2016
Primary Completion Date
November 30, 2023
Completion Date
November 30, 2023
Last Updated
August 19, 2024
NCT06625775
NCT06649331
NCT04862663
NCT05894239
NCT06557148
NCT07053085
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions